We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$57.1M
AUM Growth
+$940K
Cap. Flow
-$561K
Cap. Flow %
-0.98%
Top 10 Hldgs %
33.62%
Holding
83
New
3
Increased
22
Reduced
22
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 18.5%
3 Industrials 15.11%
4 Consumer Staples 10.14%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$640B
$2.45M 4.3%
20,777
+75
+0.4% +$9.1K
MMM icon
2
3M
MMM
$91.8B
$2.27M 3.98%
15,404
-39
-0.3% -$5.82K
ADP icon
3
Automatic Data Processing
ADP
$109B
$2.13M 3.74%
24,215
-140
-0.6% -$12.7K
MA icon
4
Mastercard
MA
$498B
$1.99M 3.49%
19,590
+860
+5% +$82.5K
CVS icon
5
CVS Health
CVS
$135B
$1.97M 3.46%
22,183
+20
+0.1% +$1.89K
PG icon
6
Procter & Gamble
PG
$340B
$1.78M 3.12%
19,825
-325
-2% -$28.2K
AAPL icon
7
Apple
AAPL
$4.97T
$1.75M 3.07%
61,940
+2,100
+4% +$55.6K
ATR icon
8
AptarGroup
ATR
$8.69B
$1.56M 2.73%
20,155
-380
-2% -$29.7K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.12T
$1.51M 2.64%
37,500
+2,620
+8% +$102K
CB icon
10
Chubb
CB
$140B
$1.47M 2.58%
11,711
+722
+7% +$91.6K
CNI icon
11
Canadian National Railway
CNI
$78.5B
$1.38M 2.41%
21,072
+60
+0.3% +$3.79K
RTX icon
12
RTX Corp
RTX
$290B
$1.29M 2.25%
20,109
+833
+4% +$55.2K
UL icon
13
Unilever
UL
$142B
$1.26M 2.2%
23,583
+471
+2% +$24.9K
ABT icon
14
Abbott
ABT
$187B
$1.25M 2.19%
29,616
+5,316
+22% +$228K
FISV
15
Fiserv Inc
FISV
$29.7B
$1.25M 2.19%
25,200
-250
-1% -$13.1K
NVS icon
16
Novartis
NVS
$302B
$1.22M 2.13%
17,174
+228
+1% +$16.6K
PEP icon
17
PepsiCo
PEP
$196B
$1.21M 2.12%
11,115
-600
-5% -$64.7K
SLB icon
18
SLB Ltd
SLB
$72.7B
$1.09M 1.92%
13,915
-80
-0.6% -$6.35K
INTC icon
19
Intel
INTC
$413B
$1.04M 1.81%
27,435
DHR icon
20
Danaher
DHR
$138B
$974K 1.71%
14,015
-2,289
-14% -$162K
GILD icon
21
Gilead Sciences
GILD
$165B
$903K 1.58%
11,420
+969
+9% +$78.7K
XYL icon
22
Xylem
XYL
$28.5B
$883K 1.55%
16,846
+86
+0.5% +$4.22K
ORCL icon
23
Oracle
ORCL
$339B
$814K 1.43%
20,711
-125
-0.6% -$5.09K
MSFT icon
24
Microsoft
MSFT
$2.9T
$802K 1.4%
13,938
-50
-0.4% -$2.82K
MRK icon
25
Merck
MRK
$322B
$752K 1.32%
12,637
-26
-0.2% -$1.52K

Similar funds

Nancy E. Dempze's Q3 2016 Portfolio in Review

As of Q3 2016, Nancy E. Dempze held 83 positions worth $57.1M, up 1.7% from $56.2M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nancy E. Dempze's Q3 2016 filing shows 3 new, 22 increased, 22 reduced and 5 closed positions. Its largest new stake was Fortive: 8,677 shares worth $278K. The largest sale was Chevron, an estimated $362K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Nancy E. Dempze's largest Q3 2016 buy was Fortive: 8,677 shares worth $278K.
  • Nancy E. Dempze added most to Abbott in Q3 2016, an estimated $228K increase.
  • Nancy E. Dempze's biggest Q3 2016 reduction was Perrigo, cutting an estimated $231K.
  • Nancy E. Dempze fully exited Chevron in Q3 2016, selling an estimated $362K.
  • Nancy E. Dempze's ten largest holdings make up 34% of its $57.1M portfolio in Q3 2016.
  • Nancy E. Dempze opened 3 new positions and closed 5 in Q3 2016.
  • Nancy E. Dempze's portfolio value rose 1.7% quarter-over-quarter to $57.1M.

Based on Nancy E. Dempze's 13F filing for Q3 2016, filed 16 Nov 2016.